Clinical Trials in San Antonio

Showing 941-960 of 7,028 trials

Genetic Investigation of Cancer Predisposition

NCT04620278

Clinical information and samples (blood, saliva, and tumor) will be collected from patients with multiple cancers and/or a family history of cancer as well as from affected and unaffected relatives; samples will be systematically sequenced and evaluated for candidate driver mutations.

Genetic PredispositionCancer

The University of Texas Health Science Center at San Antonio100 participantsStarted Oct 2026

San Antonio, Texas, United States

RECRUITING< 1 mile

Chromosome 18 Clinical Research Center

NCT00227253

Our vision, that of the researchers at the University of Texas Health Science Center at San Antonio, is that every person with a chromosome 18 abnormality will have an autonomous and healthy life. Our mission is to provide families affected by chromosome 18 abnormalities with comprehensive medical and educational information. Our goals are to provide definitive medical and education resources for the families of individuals with chromosome 18 abnormalities; perform and facilitate groundbreaking clinical and basic research relating to the syndromes of chromosome 18; and to provide treatments to help these individuals overcome the effects of their chromosome abnormality.

Chromosome AberrationsGrowth Hormone DeficiencyHypomyelination

The University of Texas Health Science Center at San Antonio4,000 participantsStarted Sep 1993

San Antonio, Texas, United States • San Antonio, Texas, United States

Genetic Investigation of Cancer Predisposition

Chromosome 18 Clinical Research Center

Find Trials by Condition in San Antonio

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

Using TropoCells(R) Autologous Platelet-Rich Fibrin (PRF) to Treat Chronic Non-Healing Wounds

A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)

A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Neurostimulation to Improve NOWS Outcomes

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.

Acute Hip Fracture Study in Patients 65 Years or Greater

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease